vs
Side-by-side financial comparison of Lifeway Foods, Inc. (LWAY) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $55.4M, roughly 1.5× Lifeway Foods, Inc.). Lifeway Foods, Inc. runs the higher net margin — 4.6% vs -38.1%, a 42.6% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 18.0%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 11.4%).
Lifeway Foods is an Illinois-based health food company founded in 1986. They are a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
LWAY vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $55.4M | $83.1M |
| Net Profit | $2.5M | $-31.6M |
| Gross Margin | 27.8% | 64.9% |
| Operating Margin | 6.8% | -4.1% |
| Net Margin | 4.6% | -38.1% |
| Revenue YoY | 18.0% | 20.2% |
| Net Profit YoY | 1688.1% | -27.9% |
| EPS (diluted) | $0.15 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $55.4M | $76.4M | ||
| Q3 25 | $57.1M | $83.3M | ||
| Q2 25 | $53.9M | $79.2M | ||
| Q1 25 | $46.1M | $69.2M | ||
| Q4 24 | $46.9M | $68.2M | ||
| Q3 24 | $46.1M | $58.4M | ||
| Q2 24 | $49.2M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $2.5M | $-29.8M | ||
| Q3 25 | $3.5M | $-21.4M | ||
| Q2 25 | $4.2M | $-19.6M | ||
| Q1 25 | $3.5M | $-24.7M | ||
| Q4 24 | $-160.0K | $-18.9M | ||
| Q3 24 | $3.0M | $-21.0M | ||
| Q2 24 | $3.8M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | 27.8% | 60.6% | ||
| Q3 25 | 28.7% | 64.8% | ||
| Q2 25 | 28.6% | 65.4% | ||
| Q1 25 | 23.9% | 63.9% | ||
| Q4 24 | 25.3% | 64.0% | ||
| Q3 24 | 25.7% | 63.2% | ||
| Q2 24 | 27.0% | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 6.8% | -40.6% | ||
| Q3 25 | 8.8% | -27.8% | ||
| Q2 25 | 10.8% | -28.0% | ||
| Q1 25 | 3.4% | -39.7% | ||
| Q4 24 | 1.5% | -28.9% | ||
| Q3 24 | 9.1% | -38.4% | ||
| Q2 24 | 11.0% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 4.6% | -39.1% | ||
| Q3 25 | 6.2% | -25.7% | ||
| Q2 25 | 7.9% | -24.7% | ||
| Q1 25 | 7.7% | -35.8% | ||
| Q4 24 | -0.3% | -27.6% | ||
| Q3 24 | 6.5% | -35.9% | ||
| Q2 24 | 7.7% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.15 | $-0.54 | ||
| Q3 25 | $0.23 | $-0.38 | ||
| Q2 25 | $0.28 | $-0.35 | ||
| Q1 25 | $0.23 | $-0.45 | ||
| Q4 24 | $0.00 | $-0.34 | ||
| Q3 24 | $0.19 | $-0.40 | ||
| Q2 24 | $0.25 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.6M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $85.8M | $347.7M |
| Total Assets | $105.6M | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $5.6M | $286.5M | ||
| Q3 25 | $23.0M | $294.3M | ||
| Q2 25 | $21.2M | $302.7M | ||
| Q1 25 | $19.4M | $316.2M | ||
| Q4 24 | $16.7M | $333.7M | ||
| Q3 24 | $20.6M | $196.8M | ||
| Q2 24 | $14.6M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $85.8M | $365.9M | ||
| Q3 25 | $82.8M | $380.3M | ||
| Q2 25 | $78.7M | $385.8M | ||
| Q1 25 | $74.2M | $389.2M | ||
| Q4 24 | $71.9M | $402.2M | ||
| Q3 24 | $71.5M | $241.2M | ||
| Q2 24 | $68.0M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $105.6M | $508.1M | ||
| Q3 25 | $109.5M | $511.5M | ||
| Q2 25 | $98.3M | $513.1M | ||
| Q1 25 | $93.7M | $519.4M | ||
| Q4 24 | $90.5M | $534.0M | ||
| Q3 24 | $91.3M | $374.1M | ||
| Q2 24 | $84.9M | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $267.0K | — |
| Free Cash FlowOCF − Capex | $-17.4M | — |
| FCF MarginFCF / Revenue | -31.5% | — |
| Capex IntensityCapex / Revenue | 31.9% | — |
| Cash ConversionOCF / Net Profit | 0.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $267.0K | $-10.3M | ||
| Q3 25 | $6.9M | $-6.6M | ||
| Q2 25 | $3.9M | $-15.0M | ||
| Q1 25 | $-150.0K | $-17.0M | ||
| Q4 24 | $-2.6M | $-32.4M | ||
| Q3 24 | $7.5M | $-18.8M | ||
| Q2 24 | $6.5M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-17.4M | $-12.2M | ||
| Q3 25 | $1.8M | $-9.5M | ||
| Q2 25 | $1.6M | $-17.8M | ||
| Q1 25 | $-2.4M | $-18.8M | ||
| Q4 24 | $-3.8M | $-33.6M | ||
| Q3 24 | $5.9M | $-19.0M | ||
| Q2 24 | $5.1M | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | -31.5% | -15.9% | ||
| Q3 25 | 3.1% | -11.4% | ||
| Q2 25 | 3.0% | -22.5% | ||
| Q1 25 | -5.1% | -27.2% | ||
| Q4 24 | -8.2% | -49.2% | ||
| Q3 24 | 12.8% | -32.6% | ||
| Q2 24 | 10.4% | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 31.9% | 2.4% | ||
| Q3 25 | 9.0% | 3.4% | ||
| Q2 25 | 4.3% | 3.5% | ||
| Q1 25 | 4.8% | 2.7% | ||
| Q4 24 | 2.7% | 1.7% | ||
| Q3 24 | 3.3% | 0.4% | ||
| Q2 24 | 2.9% | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 0.11× | — | ||
| Q3 25 | 1.96× | — | ||
| Q2 25 | 0.92× | — | ||
| Q1 25 | -0.04× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.50× | — | ||
| Q2 24 | 1.73× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LWAY
| Drinkable Kefirotherthan Pro Bugs | $47.8M | 86% |
| Cheese | $4.7M | 8% |
| Cream And Other | $1.7M | 3% |
| Other | $1.2M | 2% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
